Pneumostem(Pneumostem) - 在研适应症：支气管肺发育不良_专利_临床

概要

基本信息

药物类型

间充质干细胞疗法

别名-

靶点-

作用机制-

治疗领域

在研适应症

非在研适应症

原研机构

在研机构

非在研机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

13

项与 Pneumostem 相关的临床试验

NCT04003857 / Recruiting临床2期

Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial

This is a follow-up study to investigate the long-term safety and efficacy of PNEUMOSTEM® versus placebo, for the treatment of BPD in premature infants. Subjects who participated in and completed the initial stage of the Phase II trial (NCT03392467) will be followed-up until 60 months of corrected age

开始日期2019-07-05

申办/合作机构

MEDIPOST Co., Ltd.

NCT03392467 / Recruiting临床2期

A Multi-center, Randomized, Double-blind, Parallel, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of PNEUMOSTEM for the Prevention and Treatment of Severe Bronchopulmonary Dysplasia in Premature Infants

This study is to evaluate the efficacy and safety of PNEUMOSTEM® for the Prevention and Treatment of Severe Bronchopulmonary Dysplasia (Severe BPD) in Premature Infants. Half of subjects will receive PNEUMOSTEM, while the other half will receive a placebo.

开始日期2018-08-13

申办/合作机构

MEDIPOST Co., Ltd.

NCT02890953 / Unknown status临床2期IIT

Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of IVH in Premature Infants (Phase 2a)

The objective of this study is to evaluate the efficacy and safety of a single intraventricular administration of Pneumostem® for treatment of Intraventricular hemorrhage (IVH) in high-risk premature infants by comparing Pneumostem-treated group with a control group.

开始日期2017-03-28

申办/合作机构

Samsung Medical Center

100 项与 Pneumostem 相关的临床结果

登录后查看更多信息

100 项与 Pneumostem 相关的转化医学

登录后查看更多信息

100 项与 Pneumostem 相关的专利（医药）

登录后查看更多信息

100 项与 Pneumostem 相关的药物交易

登录后查看更多信息

研发状态

10 条进展最快的记录,

登录

后查看更多信息

适应症	最高研发状态	国家/地区	公司	日期
支气管肺发育不良	临床2期	韩国	MEDIPOST Co., Ltd.	2013-04-01
早产	临床2期	韩国	MEDIPOST Co., Ltd.	2013-04-01

登录后查看更多信息

临床结果

适应症

分期

评价

查看全部结果

研究	分期	人群特征	评价人数	分组	结果	评价	发布日期


NCT01828957 (Pubmed) 人工标引	临床2期	支气管肺发育不良	66	Pneumostem	獵膚鑰鏇構廠築鬱選簾(憲範觸網鹽顧廠鬱獵遞) = 膚繭衊鬱餘選願廠蓋齋獵積鹽顧願鹽簾膚觸獵 (製網憲艱蓋簾鏇餘餘廠 ) 更多	积极	2021-08-01
				Placebo	獵膚鑰鏇構廠築鬱選簾(憲範觸網鹽顧廠鬱獵遞) = 夢糧選憲餘糧顧獵遞糧獵積鹽顧願鹽簾膚觸獵 (製網憲艱蓋簾鏇餘餘廠 ) 更多
NCT01297218 (Pubmed) 人工标引	临床1期	阿尔茨海默症	9	hUCB-MSCs (low-dose)	觸獵網遞齋製衊繭網醖(繭構齋鏇獵製選積憲憲) = No patient showed serious adverse events including fever during 膚網獵範網繭蓋顧衊築 (艱憲餘壓築鏇簾鹽範廠 ) 更多	积极	2015-07-26
				hUCB-MSCs (high-dose)